Review of evidence supporting the use of nasal corticosteroid irrigation for chronic rhinosinusitis

CONCLUSION: Designing more robust clinical trials may help determine if CSI is a valid treatment option. Until more evidence supporting CSI use exists, health care professionals should strongly consider choosing FDA-approved therapies for the treatment of CRS.PMID:36116748 | DOI:10.1016/j.anai.2022.09.008

Source: Annals of Allergy, Asthma and Immunology - September 18, 2022 Category: Allergy & Immunology Authors: Jonathan A Bernstein Andrew A White Joseph K Han David M Lang David Elkayam Fuad M Baroody Source Type: research